TDACW • NASDAQ
Translational Development Acquisition Corp.
$1.89
Stock Details
| Market Cap | 330,324,999 |
|---|---|
| Day Change | 0.38 (25.17%) |
| Volume | 44,975.346 |
| Avg Volume | 33,006.654 |
| Price Range | 0.325-2.68 |
Overview
| Country | US |
|---|---|
| Sector | Financial Services |
| Industry | Shell Companies |
| Exchange | NASDAQ |
Company Profile
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
Financial Overview
| 52 Week High | 2.45 |
|---|---|
| 52 Week High Date | 2026-06-04 |
| 52 Week Low | 0.06 |
| 52 Week Low Date | 2026-04-24 |
| 10D Avg Trading Vol | 0.01696 |
| YTD Price Return Daily | 387.0968 |
| MTD Price Return Daily | 5.9649 |